|
C1ORF131 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62458935193399E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.4432899320127E-15 |
| Normal-vs-Stage2 |
1.41050504609552E-11 |
| Normal-vs-Stage3 |
4.44089209850063E-16 |
| Normal-vs-Stage4 |
1.63269398001376E-12 |
| Stage1-vs-Stage2 |
2.766400E-01 |
| Stage1-vs-Stage3 |
2.360400E-02 |
| Stage1-vs-Stage4 |
3.076200E-03 |
| Stage2-vs-Stage3 |
5.711000E-01 |
| Stage2-vs-Stage4 |
1.243610E-01 |
| Stage3-vs-Stage4 |
2.651800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
5.30129995457429E-09 |
| Normal-vs-Asian |
4.60340000008053E-07 |
| Caucasian-vs-AfricanAmerican |
4.830000E-01 |
| Caucasian-vs-Asian |
9.244100E-02 |
| AfricanAmerican-vs-Asian |
1.065240E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.11022302462516E-16 |
| Normal-vs-Female |
1.62447832963153E-12 |
| Male-vs-Female |
3.390800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.62647673107585E-12 |
| Normal-vs-Age(41-60Yrs) |
2.22044604925031E-16 |
| Normal-vs-Age(61-80Yrs) |
1.64490643328463E-12 |
| Normal-vs-Age(81-100Yrs) |
8.87759999956828E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.163400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.673180E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.920830E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.583200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.473200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.204800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.082500E-03 |
| Classical-VS-Follicular |
3.083400E-01 |
| Classical-VS-Other |
7.014200E-01 |
| Classical-VS-Normal |
1.62458935193399E-12 |
| Tall-VS-Follicular |
5.910500E-02 |
| Tall-VS-Other |
4.803800E-01 |
| Tall-VS-Normal |
1.72029057665668E-12 |
| Follicular-VS-Other |
9.687200E-01 |
| Follicular-VS-Normal |
2.69206879011108E-12 |
| Other-VS-Normal |
1.519020E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.44089209850063E-16 |
| Normal-vs-N1 |
5.23959764464621E-11 |
| N0-vs-N1 |
4.644200E-01 |
|
|
